Clinical Trials Browser

Adenocarcinoma Of Esophagus × Endoscopic Mucosal Resection × Gastrointestinal × Clear all

NCT04929392 2025-09-04

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

Phase 2 Active not recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT02583087 2017-08-28

ESTEBAN

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms

NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Phase NA Unknown

GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions